Current liabilities increased 40.3%
Current liabilities changed +40.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +40.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +48.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating cash flow changed -66.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -1813 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed -67.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +39.3% from the comparable as-filed period.
Operating margin changed +607 basis points from the comparable as-filed period.
Cash & equivalents changed +173.9% from the comparable as-filed period.
Research & development changed +27.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -2175 basis points from the comparable as-filed period.
Operating income changed +3397.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Receivables / revenue changed -1357 basis points from the comparable as-filed period.
Operating cash-flow margin changed -2821 basis points from the comparable as-filed period.
Shares outstanding changed +2.2% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
SBC / revenue changed -149 basis points from the comparable as-filed period.
Current ratio changed -23.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current assets changed +7.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed -9.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed -146 basis points from the comparable as-filed period.
Stock-based compensation changed +14.7% from the comparable as-filed period.
Trade receivables changed -0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Inventory changed -75.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital changed +56.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +39.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed -49.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +38.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed +20.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed +1476 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +209.3% from the comparable as-filed period.
Revenue changed +52.2% from the comparable as-filed period.
Operating margin changed +9864 basis points from the comparable as-filed period.
Research & development changed +33.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed +447.8% from the comparable as-filed period.
Inventory / revenue changed -2691 basis points from the comparable as-filed period.
SBC / revenue changed -280 basis points from the comparable as-filed period.
Operating income changed +1118.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Receivables / revenue changed -5166 basis points from the comparable as-filed period.
R&D / revenue changed -246 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1178 basis points from the comparable as-filed period.
Shares outstanding changed -2.8% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
Stock-based compensation changed +13.1% from the comparable as-filed period.
Current liabilities changed +0.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.